Sasha Damouni Ellis | Vice President of Corporate Affairs and Investor Relations |
Scott Braunstein | Chairman and Chief Executive Officer |
Christy Shafer | Chief Commercial Officer |
Joe Hulihan | Chief Medical Officer |
Steve Pfanstiel | Chief Financial Officer and Chief Operating Officer |
Brian Abrahams | RBC Capital Markets |
Joon Lee | Truist Securities |
Rudy | SVB Securities |
Andrew Tsai | Jefferies |
Charles Duncan | Cantor Fitzgerald |
Douglas Tsao | H.C. Wainwright |
Jay Olson | Oppenheimer |
Brian Skorney | Baird |
Jason Butler | JMP Securities |
Greetings everyone and welcome to the Marinus Pharmaceuticals’ Fourth Quarter and Full-Year 2022 Financial Results and Business Update Call. At this time, all participants are in a listen-only mode. After the speakers’ presentation, there will be a question-and-answer session. [Operator Instructions]
It is now my pleasure to introduce your host, Sasha Damouni Ellis, Vice President of Corporate Affairs and Investor Relations.